Dr. Gottschalk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
262 Danny Thomas Pl
Memphis, TN 38105Phone+1 901-595-3300Fax+1 901-595-3842
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1998 - 2001
- Baylor College of Medicine (Houston)Residency, Pediatrics, 1995 - 1998
- University of Gottingen Faculty of MedicineClass of 1992
Certifications & Licensure
- TN State Medical License 2017 - 2025
- TX State Medical License 2001 - 2024
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) Start of enrollment: 2003 Sep 01
- Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL) Start of enrollment: 2007 Aug 01
- LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA) Start of enrollment: 2007 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 566 citationsHER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation TrialNabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Kevin Bielamowicz, Mamta Kalra
JAMA Oncology. 2017-08-01 - 191 citationsT cells redirected to EphA2 for the immunotherapy of glioblastoma.Kevin Chow, Swati Naik, Sunitha Kakarla, Vita S. Brawley, Donald R. Shaffer
Molecular Therapy. 2013-03-01 - 44 citationsA vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading.Stephen Gottschalk, Feng Yu, Minjun Ji, Sunitha Kakarla, Xiao-Tong Song
Plos One. 2013-12-12
Journal Articles
- EBV/LMP-specific T Cells Maintain Remissions of T and B Cell EBV Lymphomas After Allogeneic Bone Marrow TransplantationStephen Gottschalk, Rayne Rouce, Catherine M Bollard, Malcolm K Brenner, Helen E Heslop, Blood
Abstracts/Posters
- CD70-Specific CAR T Cells Have Potent Activity Against Acute Myeloid Leukemia (AML) without HSC ToxicityStephen Gottschalk, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing P...Stephen Gottschalk, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-CellsStephen Gottschalk, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- St. Jude Explores Curative Therapies for Sickle Cell DiseaseAugust 22nd, 2024
- Pan-Cancer Analysis Uncovers a New Class of Promising CAR T--Cell Immunotherapy TargetsMay 3rd, 2024
- Novel Leukaemia Therapy Aims to Treat Sick Kids Before Time Runs OutNovember 14th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: